Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 275

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

Open access
Hamdane, Nourdine, Jühling, Frank, Crouchet, Emilie, El Saghire, Houssein, Thumann, Christine, Oudot, Marine A., Bandiera, Simonetta, Saviano, Antonio, Ponsolles, Clara, Roca Suarez, Armando Andres, Li, Shen, Fujiwara, Naoto, Ono, Atsushi, Davidson, Irwin, Bardeesy, Nabeel, Schmidl, Christian, Bock, Christoph, Schuster, Catherine, Lupberger, Joachim, Habersetzer, François, Doffoël, Michel, Piardi, Tullio, Sommacale, Daniele, Imamura, Michio, Uchida, Takuro, Ohdan, Hideki, Aikata, Hiroshi, Chayama, Kazuaki, Boldanova, Tujana, Pessaux, Patrick, Fuchs, Bryan C., Hoshida, Yujin, Zeisel, Mirjam B., Duong, François H.T., Baumert, Thomas F. · 2019 · Gastroenterology

Abstract

BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is an important risk factor for hepatocellular carcinoma (HCC). Despite effective antiviral therapies, the risk for HCC is decreased but not eliminated after a sustained virologic response (SVR) to direct-acting antiviral (DAA) agents, and the risk is higher in patients with advanced fibrosis. We investigated HCV-induced epigenetic alterations that might affect risk for HCC after DAA treatment in patients and mice with humanized livers. METHODS: We performed genome-wide ChIPmentation-based ChIP-Seq and RNA-seq analyses of liver tissues from 6 patients without HCV infection (controls), 18 patients with chronic HCV infection, 8 patients with chronic HCV infection cured by DAA treatment, 13 patients with chronic HCV infection cured by interferon therapy, 4 patients with chronic hepatitis B virus infection, and 7 patients with nonalcoholic steatohepatitis in Europe and Japan. HCV-induced epigenetic modifications were mapped by comparative analyses with modifications associated with other liver disease etiologies. uPA/SCID mice were engrafted with human hepatocytes to create mice with humanized livers and given injections of HCV-infected serum samples from patients; mice were given DAAs to eradicate the virus. Pathways associated with HCC risk were identified by integrative pathway analyses and validated in analyses of paired HCC tissues from 8 patients with an SVR to DAA treatment of HCV infection. RESULTS: We found chronic HCV infection to induce specific genome-wide changes in H3K27ac, which correlated with changes in expression of mRNAs and proteins. These changes persisted after an SVR to DAAs or interferon-based therapies. Integrative pathway analyses of liver tissues from patients and mice with humanized livers demonstrated that HCV-induced epigenetic alterations were associated with liver cancer risk. Computational analyses associated increased expression of SPHK1 with HCC risk. We validated these findings in an independent cohort of patients with HCV-related cirrhosis (n = 216), a subset of which (n = 21) achieved viral clearance. CONCLUSIONS: In an analysis of liver tissues from patients with and without an SVR to DAA therapy, we identified epigenetic and gene expression alterations associated with risk for HCC. These alterations might be targeted to prevent liver cancer in patients treated for HCV infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2019.02.038

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 275

Metadata

Authors
Hamdane, N., Jühling, F., Crouchet, E., El Saghire, H., Thumann, C., Oudot, M. A., Bandiera, S., Saviano, A., Ponsolles, C., Roca Suarez, A. A., Li, S., Fujiwara, N., Ono, A., Davidson, I., Bardeesy, N., Schmidl, C., Bock, C., Schuster, C., Lupberger, J., Habersetzer, F., Doffoël, M., Piardi, T., Sommacale, D., Imamura, M., Uchida, T., Ohdan, H., Aikata, H., Chayama, K., Boldanova, T., Pessaux, P., Fuchs, B. C., Hoshida, Y., Zeisel, M. B., Duong, F. H. T., & Baumert, T. F.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2019-06
Volume
156
Issue
8
Pages
2313-2329.e7
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2918873588
Cited by
275
References
40
FWCI
21.55
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response. https://app.cochat.ai/papers/10.1053/j.gastro.2019.02.038
The paper
Hamdane, N., Jühling, F., Crouchet, E., El Saghire, H., Thumann, C., Oudot, M. A., Bandiera, S., Saviano, A., Ponsolles, C., Roca Suarez, A. A., Li, S., Fujiwara, N., Ono, A., Davidson, I., Bardeesy, N., Schmidl, C., Bock, C., Schuster, C., Lupberger, J., . . . Baumert, T. F. (2019). HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response. Gastroenterology. https://doi.org/10.1053/j.gastro.2019.02.038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.